Curacle Co Ltd (365270)

Currency in KRW
5,000
-70(-1.38%)
Delayed Data·
365270 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
365270 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4,8255,140
52 wk Range
4,2059,100
Key Statistics
Bid/Ask
4,970.00 / 4,995.00
Prev. Close
5,070
Open
5,080
Day's Range
4,825-5,140
52 wk Range
4,205-9,100
Volume
158.3K
Average Volume (3m)
160.84K
1-Year Change
-20.29%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
365270 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral

Curacle Co Ltd Company Profile

Curacle Co., Ltd., a bio-venture business, engages in the research and development of drugs for diseases caused by aging process and damage to blood vessels. Its products cover age-related vascular diseases, intractable metabolic diseases, and cancer targeting/immunotherapy. The company’s products in pipeline include CU06, which covers treatment and medical indications, such as diabetic macular edema/retinopathy, acute respiratory distress syndrome, myocardial infarction, stroke treatment, concomitantly used with immunotherapy, inflammatory bowel disease treatment, and hereditary angioedema; CU03, which is in Phase 2a clinical trial study for the treatment of age-related macular degeneration; and CU01, a diabetic nephropathy medicine that completed Phase 2a clinical trial. Its products in back-up pipeline include CU02, a product for nonalcoholic steatohepatitis treatment; CU04, a product for the treatment of cancer (c-Myc inhibitor); and CU05, a product for the treatment of cancer (Amigo2-PDK1 inhibitor). The company was founded in 2016 and is based in Seoul, South Korea.

Compare 365270 to Peers and Sector

Metrics to compare
365270
Peers
Sector
Relationship
P/E Ratio
−4.4x−4.5x−0.5x
PEG Ratio
0.11−0.100.00
Price/Book
2.7x2.2x2.6x
Price / LTM Sales
62.7x5.1x3.2x
Upside (Analyst Target)
-0.0%40.5%
Fair Value Upside
Unlock15.6%4.4%Unlock

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-296.00 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

365270 Income Statement

FAQ

What Stock Exchange Does Curacle Co Trade On?

Curacle Co is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Curacle Co?

The stock symbol for Curacle Co is "365270."

What Is the Curacle Co Market Cap?

As of today, Curacle Co market cap is 71.03B.

What Is Curacle Co's Earnings Per Share (TTM)?

The Curacle Co EPS (TTM) is -1,160.84.

From a Technical Analysis Perspective, Is 365270 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Curacle Co Stock Split?

Curacle Co has split 0 times.

How Many Employees Does Curacle Co Have?

Curacle Co has 0 employees.

What is the current trading status of Curacle Co (365270)?

As of 25 Jul 2025, Curacle Co (365270) is trading at a price of 5,000.00, with a previous close of 5,070.00. The stock has fluctuated within a day range of 4,825.00 to 5,140.00, while its 52-week range spans from 4,205.00 to 9,100.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.